CoxHealth Partnering With Mayo Clinic For Clinical Trial

CoxHealth Partnering With Mayo Clinic For Clinical Trial

CoxHealth Partnering With Mayo Clinic For Clinical Trial

CoxHealth says it has joined a clinical trial with the Mayo Clinic looking into how convalescent plasma may help treat patients suffering from COVID-19.

The health system is currently treating its first patient with the developing method of treatment.

A press release from CoxHealth says, “Plasma has historically been utilized in the early treatment of viral diseases before a vaccine becomes available. In the case of COVID-19, it is hoped that the antibodies in the plasma of recovered patients will offer help to those currently battling severe or life-threatening cases of the disease.”

Patients who are interested and potentially eligible to donate convalescent plasma should reach out to their primary care provider or CoxHealthAccountableCare@coxhealth.com.

The provider will confirm that the patient meets eligibility requirements and send documentation to Community Blood Center of the Ozarks (CBCO).

Eligible donors will set up an appointment with CBCO to donate plasma, and that convalescent plasma will stay in the local community for patients with severe COVID-19 infections to potentially benefit from this product.

Recommended Posts

Loading...